Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda

Authors: Abdhalah K Ziraba, Josephine Bwogi, Alice Namale, Caroline W Wainaina, Harriet Mayanja-Kizza

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Hepatitis B virus (HBV) infection is a global public health challenge. Prevalence of current hepatitis B virus infection in the general population in Uganda is about 10%. Health care workers (HCW) have an extra risk of getting infected from their workplace and yet they are not routinely vaccinated against HBV infection. This study aimed at estimating prevalence of hepatitis B virus infection and associated risk factors among health care workers in a tertiary hospital in Uganda.

Methods

Data were obtained from a cross sectional survey conducted in Mulago, a national referral and teaching hospital in Uganda among health care workers in 2003. A proportionate to size random sample was drawn per health care worker category. A structured questionnaire was used to collect data on socio-demographic characteristics and risk factors. ELISA was used to test sera for HBsAg, anti-HBs and total anti-HBc. Descriptive and logistic regression models were used for analysis.

Results

Among the 370 participants, the sero-prevalence of current hepatitis B virus infection was 8.1%; while prevalence of life time exposure to hepatitis B virus infection was 48.1%. Prevalence of needle stick injuries and exposure to mucous membranes was 67.8% and 41.0% respectively. Cuts were also common with 31.7% of doctors reporting a cut in a period of one year preceding the survey. Consistent use of gloves was reported by 55.4% of respondents. The laboratory technicians (18.0% of respondents) were the least likely to consistently use gloves. Only 6.2% of respondents were vaccinated against hepatitis B virus infection and 48.9% were susceptible and could potentially be protected through vaccination. Longer duration in service was associated with a lower risk of current infection (OR = 0.13; p value = 0.048). Being a nursing assistant (OR = 17.78; p value = 0.007) or a laboratory technician (OR = 12.23; p value = 0.009) were associated with a higher risk of current hepatitis B virus infection. Laboratory technicians (OR = 3.99; p value = 0.023) and individuals with no training in infection prevention in last five years (OR = 1.85; p value = 0.015) were more likely to have been exposed to hepatitis B virus infection before.

Conclusions

The prevalence of current and life time exposure to hepatitis B virus infection was high. Exposure to potentially infectious body fluids was high and yet only a small percentage of HCW were vaccinated. There is need to vaccinate all health care workers as a matter of policy and ensure a safer work environment.
Literature
1.
go back to reference Kane M: Global programme for control of hepatitis B infection. Vaccine. 1995, S47-49. 13 Kane M: Global programme for control of hepatitis B infection. Vaccine. 1995, S47-49. 13
2.
go back to reference Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M: Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ. 1999, 77 (10): 801-807.PubMedPubMedCentral Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M: Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ. 1999, 77 (10): 801-807.PubMedPubMedCentral
3.
go back to reference Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV: Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004, 38 (10 Suppl 3): S158-168. 10.1097/00004836-200411003-00008.CrossRefPubMed Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV: Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004, 38 (10 Suppl 3): S158-168. 10.1097/00004836-200411003-00008.CrossRefPubMed
4.
go back to reference Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS: A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005, 34 (6): 1329-1339. 10.1093/ije/dyi206.CrossRefPubMed Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS: A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005, 34 (6): 1329-1339. 10.1093/ije/dyi206.CrossRefPubMed
5.
go back to reference World Health Organization (WHO) (ed): Hepatitis B. 2002, Geneva, World Health Organization, Department of Communicable Disease Surveillance and Response World Health Organization (WHO) (ed): Hepatitis B. 2002, Geneva, World Health Organization, Department of Communicable Disease Surveillance and Response
6.
go back to reference Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF: Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. African Health Sciences. 2009, 9 (2): Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF: Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. African Health Sciences. 2009, 9 (2):
7.
go back to reference Ministry of Health (MOH) [Uganda], ORC Macro: Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. 2006, Calverton, Maryland, USA: Ministry of Health and ORC Macro Ministry of Health (MOH) [Uganda], ORC Macro: Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. 2006, Calverton, Maryland, USA: Ministry of Health and ORC Macro
8.
go back to reference West DJ: The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci. 1984, 287 (2): 26-33. 10.1097/00000441-198403000-00006.CrossRefPubMed West DJ: The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci. 1984, 287 (2): 26-33. 10.1097/00000441-198403000-00006.CrossRefPubMed
9.
go back to reference Taylor R, Sladden T, Levy S, Gust I, Macaskill P, Rushworth L, Gaxibarich G: A seroepidemiological study of hepatitis B amongst Fiji health care workers. Southeast Asian J Trop Med Public Health. 1991, 22 (4): 567-576.PubMed Taylor R, Sladden T, Levy S, Gust I, Macaskill P, Rushworth L, Gaxibarich G: A seroepidemiological study of hepatitis B amongst Fiji health care workers. Southeast Asian J Trop Med Public Health. 1991, 22 (4): 567-576.PubMed
10.
go back to reference Iserson KV, Criss EA: Hepatitis B prevalence in emergency physicians. Ann Emerg Med. 1985, 14 (2): 119-122. 10.1016/S0196-0644(85)81071-4.CrossRefPubMed Iserson KV, Criss EA: Hepatitis B prevalence in emergency physicians. Ann Emerg Med. 1985, 14 (2): 119-122. 10.1016/S0196-0644(85)81071-4.CrossRefPubMed
11.
go back to reference Pruss-Ustun A, Rapiti E, Hutin Y: Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005, 48 (6): 482-490. 10.1002/ajim.20230.CrossRefPubMed Pruss-Ustun A, Rapiti E, Hutin Y: Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers. Am J Ind Med. 2005, 48 (6): 482-490. 10.1002/ajim.20230.CrossRefPubMed
12.
go back to reference Daw MA, Siala IM, Warfalli MM, Muftah MI: Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors. Saudi Med J. 2000, 21 (12): 1157-1160.PubMed Daw MA, Siala IM, Warfalli MM, Muftah MI: Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors. Saudi Med J. 2000, 21 (12): 1157-1160.PubMed
13.
go back to reference Karpuch J, Scapa E, Eshchar J, Waron M, Bar-Shany S, Shwartz T: Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine. Isr J Med Sci. 1993, 29 (8): 449-452.PubMed Karpuch J, Scapa E, Eshchar J, Waron M, Bar-Shany S, Shwartz T: Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine. Isr J Med Sci. 1993, 29 (8): 449-452.PubMed
14.
go back to reference Newsom DH, Kiwanuka JP: Needle-stick injuries in an Ugandan teaching hospital. Ann Trop Med Parasitol. 2002, 96 (5): 517-522. 10.1179/000349802125001186.CrossRefPubMed Newsom DH, Kiwanuka JP: Needle-stick injuries in an Ugandan teaching hospital. Ann Trop Med Parasitol. 2002, 96 (5): 517-522. 10.1179/000349802125001186.CrossRefPubMed
15.
go back to reference Olubuyide IO, Ola SO, Aliyu B, Dosumu OO, Arotiba JT, Olaleye OA, Odaibo GN, Odemuyiwa SO, Olawuyi F: Hepatitis B and C in doctors and dentists in Nigeria. Qjm. 1997, 90 (6): 417-422. 10.1093/qjmed/90.6.417.CrossRefPubMed Olubuyide IO, Ola SO, Aliyu B, Dosumu OO, Arotiba JT, Olaleye OA, Odaibo GN, Odemuyiwa SO, Olawuyi F: Hepatitis B and C in doctors and dentists in Nigeria. Qjm. 1997, 90 (6): 417-422. 10.1093/qjmed/90.6.417.CrossRefPubMed
16.
go back to reference Ottoni CM, Penna FJ, Oliveira CG, Souza CJ: Prevalence of serologic markers of hepatitis B in dentistry students and dentists in Belo Horizonte, Brazil. Bol Oficina Sanit Panam. 1995, 118 (2): 108-114.PubMed Ottoni CM, Penna FJ, Oliveira CG, Souza CJ: Prevalence of serologic markers of hepatitis B in dentistry students and dentists in Belo Horizonte, Brazil. Bol Oficina Sanit Panam. 1995, 118 (2): 108-114.PubMed
17.
go back to reference Talaat M, Kandeel A, El-Shoubary W, Bodenschatz C, Khairy I, Oun S, Mahoney FJ: Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control. 2003, 31 (8): 469-474. 10.1016/j.ajic.2003.03.003.CrossRefPubMed Talaat M, Kandeel A, El-Shoubary W, Bodenschatz C, Khairy I, Oun S, Mahoney FJ: Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control. 2003, 31 (8): 469-474. 10.1016/j.ajic.2003.03.003.CrossRefPubMed
18.
go back to reference Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11 (2): 97-107. 10.1046/j.1365-2893.2003.00487.x.CrossRefPubMed Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11 (2): 97-107. 10.1046/j.1365-2893.2003.00487.x.CrossRefPubMed
19.
go back to reference Szmuness W, Stevens CE, Harley EJ, Zang EA, Taylor PE, Alter HJ: The immune response of healthy adults to a reduced dose of hepatitis B vaccine. J Med Virol. 1981, 8 (2): 123-129. 10.1002/jmv.1890080206.CrossRefPubMed Szmuness W, Stevens CE, Harley EJ, Zang EA, Taylor PE, Alter HJ: The immune response of healthy adults to a reduced dose of hepatitis B vaccine. J Med Virol. 1981, 8 (2): 123-129. 10.1002/jmv.1890080206.CrossRefPubMed
20.
go back to reference Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981, 1 (5): 377-385. 10.1002/hep.1840010502.CrossRefPubMed Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981, 1 (5): 377-385. 10.1002/hep.1840010502.CrossRefPubMed
21.
go back to reference Nasir K, Khan KA, Kadri WM, Salim S, Tufail K, Sheikh HZ, Ali SA: Hepatitis B vaccination among health care workers and students of a medical college. J Pak Med Assoc. 2000, 50 (7): 239-243.PubMed Nasir K, Khan KA, Kadri WM, Salim S, Tufail K, Sheikh HZ, Ali SA: Hepatitis B vaccination among health care workers and students of a medical college. J Pak Med Assoc. 2000, 50 (7): 239-243.PubMed
22.
go back to reference Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ: Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997, 157 (22): 2601-2605. 10.1001/archinte.157.22.2601.CrossRefPubMed Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ: Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997, 157 (22): 2601-2605. 10.1001/archinte.157.22.2601.CrossRefPubMed
23.
go back to reference Doebbeling BN, Ferguson KJ, Kohout FJ: Predictors of hepatitis B vaccine acceptance in health care workers. Med Care. 1996, 34 (1): 58-72. 10.1097/00005650-199601000-00005.CrossRefPubMed Doebbeling BN, Ferguson KJ, Kohout FJ: Predictors of hepatitis B vaccine acceptance in health care workers. Med Care. 1996, 34 (1): 58-72. 10.1097/00005650-199601000-00005.CrossRefPubMed
24.
go back to reference Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF: Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Vaccine. 2006, 24 (47-48): 6930-6937. 10.1016/j.vaccine.2006.08.029.CrossRefPubMed Braka F, Nanyunja M, Makumbi I, Mbabazi W, Kasasa S, Lewis RF: Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Vaccine. 2006, 24 (47-48): 6930-6937. 10.1016/j.vaccine.2006.08.029.CrossRefPubMed
25.
go back to reference Ganju SA, Goel A: Prevalence of HBV and HCV infection among health care workers (HCWs). J Commun Dis. 2000, 32 (3): 228-230.PubMed Ganju SA, Goel A: Prevalence of HBV and HCV infection among health care workers (HCWs). J Commun Dis. 2000, 32 (3): 228-230.PubMed
26.
go back to reference Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ: A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005, 54 (RR-16): 1-31.PubMed Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ: A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005, 54 (RR-16): 1-31.PubMed
27.
go back to reference Kondili LA, Ulqinaku D, Hajdini M, Basho M, Chionne P, Madonna E, Taliani G, Candido A, Dentico P, Bino S, et al: Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection. 2007, 35 (2): 94-97. 10.1007/s15010-007-6076-1.CrossRefPubMed Kondili LA, Ulqinaku D, Hajdini M, Basho M, Chionne P, Madonna E, Taliani G, Candido A, Dentico P, Bino S, et al: Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection. 2007, 35 (2): 94-97. 10.1007/s15010-007-6076-1.CrossRefPubMed
28.
go back to reference Ali NS, Jamal K, Qureshi R: Hepatitis B vaccination status and identification of risk factors for hepatitis B in health care workers. J Coll Physicians Surg Pak. 2005, 15 (5): 257-260.PubMed Ali NS, Jamal K, Qureshi R: Hepatitis B vaccination status and identification of risk factors for hepatitis B in health care workers. J Coll Physicians Surg Pak. 2005, 15 (5): 257-260.PubMed
29.
go back to reference Pavli P, Bayliss GJ, Dent OF, Lunzer MR: The prevalence of serological markers for hepatitis B virus infection in Australian Naval personnel. Med J Aust. 1989, 151 (2): 71-74-75PubMed Pavli P, Bayliss GJ, Dent OF, Lunzer MR: The prevalence of serological markers for hepatitis B virus infection in Australian Naval personnel. Med J Aust. 1989, 151 (2): 71-74-75PubMed
Metadata
Title
Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda
Authors
Abdhalah K Ziraba
Josephine Bwogi
Alice Namale
Caroline W Wainaina
Harriet Mayanja-Kizza
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-191

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine